{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T02:44:16Z","timestamp":1749005056902},"reference-count":29,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.3892\/mmr.2017.7322","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T05:29:58Z","timestamp":1503379798000},"page":"6102-6108","source":"Crossref","is-referenced-by-count":3,"title":["Effect of the hepatitis B virus S-ecdCD40L vaccine therapy in HBV transgenic mice: A vaccine-induced activation of antigen presenting dendritic cells"],"prefix":"10.3892","volume":"16","author":[{"given":"Huaqin","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songsong","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binbin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"key":"key20180108003734_b1-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"key20180108003734_b2-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.vaccine.2012.12.074","article-title":"A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice","volume":"31","author":"Buchmann","year":"2013","journal-title":"Vaccine"},{"key":"key20180108003734_b3-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"Maini","year":"2000","journal-title":"J Exp Med"},{"key":"key20180108003734_b4-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000050035","article-title":"DNA vaccines for prophylactic or therapeutic immunization against hepatitis B","volume":"44","author":"Michel","year":"2001","journal-title":"Intervirology"},{"key":"key20180108003734_b5-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/intimm\/dxh305","article-title":"A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice","volume":"17","author":"Li","year":"2005","journal-title":"Int Immunol"},{"key":"key20180108003734_b6-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0264-410X(02)00575-3","article-title":"Progress in DNA vaccine for prophylaxis and therapy of hepatitis B","volume":"21","author":"Thermet","year":"2003","journal-title":"Vaccine"},{"key":"key20180108003734_b7-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"key20180108003734_b8-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/clim.2002.5245","article-title":"Reduction in the circulating pDC1\/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection","volume":"104","author":"Beckebaum","year":"2002","journal-title":"Clin Immunol"},{"key":"key20180108003734_b9-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.1128\/JVI.76.17.8609-8620.2002","article-title":"Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: Implications for immunotherapy of persistent viral infections","volume":"76","author":"Kakimi","year":"2002","journal-title":"J Virol"},{"key":"key20180108003734_b10-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 ligand","volume":"67","author":"Van Kooten","year":"2000","journal-title":"J Leukoc Biol"},{"key":"key20180108003734_b11-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"key20180108003734_b12-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1615\/CritRevImmunol.v23.i12.50","article-title":"CD40 and dendritic cell function","volume":"23","author":"O'Sullivan","year":"2003","journal-title":"Crit Rev Immunol"},{"key":"key20180108003734_b13-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.180.4.1263","article-title":"Activation of human dendritic cells through CD40 cross-linking","volume":"180","author":"Caux","year":"1994","journal-title":"J Exp Med"},{"key":"key20180108003734_b14-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","article-title":"Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation","volume":"184","author":"Cella","year":"1996","journal-title":"J Exp Med"},{"key":"key20180108003734_b15-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1111\/j.1365-2893.2011.01470.x","article-title":"Construction of the HBV S-ecdCD40L fusion gene and effects of HBV S-ecdCD40L modification on function of dendritic cells","volume":"18","author":"Wu","year":"2011","journal-title":"J Viral Hepat"},{"key":"key20180108003734_b16-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.179.6.1823","article-title":"Propagation of dendritic cell progenitors from normal mouse liver using granulocyte\/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen","volume":"179","author":"Lu","year":"1994","journal-title":"J Exp Med"},{"key":"key20180108003734_b17-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.vaccine.2013.02.062","article-title":"Mushroom lectin enhanced immunogenicity of HBV DNA vaccine in C57BL\/6 and HBsAg-transgenic mice","volume":"31","author":"Gao","year":"2013","journal-title":"Vaccine"},{"key":"key20180108003734_b18-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment and current, and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J Viral Hepat"},{"key":"key20180108003734_b19-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"e33015","DOI":"10.1371\/journal.pone.0033015","article-title":"Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cells","volume":"7","author":"Geng","year":"2012","journal-title":"PLoS One"},{"key":"key20180108003734_b20-mmr-16-05-6102","first-page":"817580","article-title":"Therapeutic vaccination in chronic hepatitis B: Preclinical studies in the woodchuck","volume":"2010","author":"Kosinska","year":"2010","journal-title":"Hepat Res Treat"},{"key":"key20180108003734_b21-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","article-title":"Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine","volume":"19","author":"Roy","year":"2000","journal-title":"Vaccine"},{"key":"key20180108003734_b22-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1089\/vim.2014.0051","article-title":"A fusion DNA vaccine encoding middle version of HBV envelope protein fused to interleukin-21 did not enhance HBV-specific immune response in mice","volume":"27","author":"Zhang","year":"2014","journal-title":"Viral Immunol"},{"key":"key20180108003734_b23-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/liv.12530","article-title":"Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice","volume":"35","author":"Yoon","year":"2015","journal-title":"Liver Int"},{"key":"key20180108003734_b24-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"e104606","DOI":"10.1371\/journal.pone.0104606","article-title":"Dendritic cell-mediated, DNA-based vaccination against hepatitis C induces the multi-epitope-specific response of humanized, HLA transgenic mice","volume":"9","author":"Mishra","year":"2014","journal-title":"PLoS One"},{"key":"key20180108003734_b25-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1137971","article-title":"Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation","volume":"316","author":"Burgdorf","year":"2007","journal-title":"Science"},{"key":"key20180108003734_b26-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2332\/allergolint.R-06-139","article-title":"Dendritic cells: Nature and classification","volume":"56","author":"Sato","year":"2007","journal-title":"Allergol Int"},{"key":"key20180108003734_b27-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"15101","DOI":"10.1073\/pnas.2135379100","article-title":"An adenoviral vector cancer vaccine that delivers a tumor-associated antigen\/CD40-ligand fusion protein to dendritic cells","volume":"100","author":"Zhang","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108003734_b28-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cgt.2012.87","article-title":"TAA\/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases","volume":"20","author":"Deisseroth","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"key20180108003734_b29-mmr-16-05-6102","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4049\/jimmunol.172.2.1009","article-title":"Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition","volume":"172","author":"Pillarisetty","year":"2004","journal-title":"J Immunol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T13:18:11Z","timestamp":1570022291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,8,22]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.3892\/mmr.2017.7322"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7322","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}